Caroli, Anna <br/><br/>
Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial.  [electronic resource] 

 -  Lancet (London, England)  Nov 2013 
 - 1485-95 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1474-547X 
<br/><br/><label>Standard No.: </label>10.1016/S0140-6736(13)61407-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Cholecystitis, Acute--chemically induced<br/>Cholelithiasis--chemically induced<br/>Disease Progression<br/>Female<br/>Follow-Up Studies<br/>Gastrointestinal Agents--adverse effects<br/>Humans<br/>Italy<br/>Kidney--drug effects<br/>Kidney Failure, Chronic--prevention & control<br/>Magnetic Resonance Imaging<br/>Male<br/>Middle Aged<br/>Octreotide--adverse effects<br/>Organ Size--drug effects<br/>Polycystic Kidney, Autosomal Dominant--drug therapy<br/>Somatostatin--analogs & derivatives<br/>Treatment Outcome